These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 9266415)

  • 41. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
    Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
    Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's disease.
    Ziv I; Offen D; Haviv R; Stein R; Panet H; Zilkha-Falb R; Shirvan A; Barzilai A; Melamed E
    Apoptosis; 1997; 2(2):149-55. PubMed ID: 14646549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoamine-induced apoptotic neuronal cell death.
    Zilkha-Falb R; Ziv I; Nardi N; Offen D; Melamed E; Barzilai A
    Cell Mol Neurobiol; 1997 Feb; 17(1):101-18. PubMed ID: 9118202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson's disease.
    Błaszczyk JW
    Acta Neurobiol Exp (Wars); 2017; 77(1):106-112. PubMed ID: 28379221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.
    Isingrini E; Guinaudie C; C Perret L; Rainer Q; Moquin L; Gratton A; Giros B
    Sci Rep; 2017 Sep; 7(1):12432. PubMed ID: 28963508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
    Hunter RL; Dragicevic N; Seifert K; Choi DY; Liu M; Kim HC; Cass WA; Sullivan PG; Bing G
    J Neurochem; 2007 Mar; 100(5):1375-86. PubMed ID: 17254027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.
    Ziv I; Melamed E; Nardi N; Luria D; Achiron A; Offen D; Barzilai A
    Neurosci Lett; 1994 Mar; 170(1):136-40. PubMed ID: 8041491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB; Ben-Shachar D; Riederer P
    Mov Disord; 1993; 8(1):1-12. PubMed ID: 8419792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amine-related neurotoxins in Parkinson's disease: past, present, and future.
    Nagatsu T
    Neurotoxicol Teratol; 2002; 24(5):565-9. PubMed ID: 12200187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.